NL139523B - Werkwijze voor de bereiding van farmacologisch actieve verbindingen die de activiteit van gladde spieren beinvloeden. - Google Patents

Werkwijze voor de bereiding van farmacologisch actieve verbindingen die de activiteit van gladde spieren beinvloeden.

Info

Publication number
NL139523B
NL139523B NL63288065A NL288065A NL139523B NL 139523 B NL139523 B NL 139523B NL 63288065 A NL63288065 A NL 63288065A NL 288065 A NL288065 A NL 288065A NL 139523 B NL139523 B NL 139523B
Authority
NL
Netherlands
Prior art keywords
activity
influence
preparation
active compounds
pharmacologically active
Prior art date
Application number
NL63288065A
Other languages
English (en)
Dutch (nl)
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Publication of NL139523B publication Critical patent/NL139523B/xx
Priority to NL737312626A priority Critical patent/NL154726B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL63288065A 1962-01-24 1963-01-23 Werkwijze voor de bereiding van farmacologisch actieve verbindingen die de activiteit van gladde spieren beinvloeden. NL139523B (nl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL737312626A NL154726B (nl) 1962-01-24 1973-09-13 Werkwijze voor het bereiden van farmacologisch actieve verbindingen, die de activiteit van gladde spieren beinvloeden.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16849862A 1962-01-24 1962-01-24
US24459762A 1962-12-14 1962-12-14
US38550464A 1964-07-27 1964-07-27
US439086A US3341584A (en) 1962-01-24 1965-03-11 Anilides

Publications (1)

Publication Number Publication Date
NL139523B true NL139523B (nl) 1973-08-15

Family

ID=27496795

Family Applications (1)

Application Number Title Priority Date Filing Date
NL63288065A NL139523B (nl) 1962-01-24 1963-01-23 Werkwijze voor de bereiding van farmacologisch actieve verbindingen die de activiteit van gladde spieren beinvloeden.

Country Status (9)

Country Link
US (1) US3341584A (xx)
BR (1) BR6346374D0 (xx)
CH (1) CH475962A (xx)
DE (1) DE1493955B2 (xx)
DK (1) DK122662B (xx)
FR (4) FR1599658A (xx)
GB (1) GB993584A (xx)
NL (1) NL139523B (xx)
SE (1) SE334368B (xx)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759993A (en) * 1971-09-27 1973-09-18 Riker Laboratories Inc Fluoromethanesulfonic acid derivatives
US3919424A (en) * 1972-02-16 1975-11-11 Mead Johnson & Co Bronchodilator process and composition
US3993776A (en) * 1973-10-15 1976-11-23 Mead Johnson & Company Anorexigenic process and composition
US3979514A (en) * 1974-08-26 1976-09-07 Mead Johnson & Company Process for interrupting pregnancy with sulfonamidoaminophene interceptive agents
US3968242A (en) * 1974-08-26 1976-07-06 Mead Johnson & Company Sulfonamidoaminopropiophenone interceptive process
GB1482099A (en) * 1974-12-11 1977-08-03 Wyeth John & Brother Ltd Sulphonamido derivatives
US3966770A (en) * 1975-03-25 1976-06-29 Smithkline Corporation 4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol
US4044150A (en) * 1976-06-18 1977-08-23 Mead Johnson & Company Antihypertensive 4'-[1-hydroxy-2-[(1-phenoxy ethyl)-amino]ethyl]methanesulfonanilide and salts thereof and therapeutic use
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
GB2077102A (en) * 1980-06-09 1981-12-16 Bristol Myers Co Ophthalmic compositions
US4618624A (en) * 1981-12-02 1986-10-21 American Cyanamid Company 3-amino-4-hydroxy(or alkoxy)phenethanolamine derivatives and pharmacologically-acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm-blooded animals
US4404224A (en) * 1981-12-02 1983-09-13 American Cyanamid Company Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals
FR2541999B1 (fr) * 1983-03-04 1986-09-19 Bristol Myers Co Phenethanolamines et leurs utilisations
US4540581A (en) * 1984-01-31 1985-09-10 Bristol-Myers Company Topical nonsteroidal anti-inflammatory compositions and uses
CA1237079A (en) * 1983-05-23 1988-05-24 Arthur Simon Antiarrhythmic class iii process
US5089526A (en) * 1983-05-23 1992-02-18 Bristol-Myers Company Antiarrhythmic class III process
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
US4507320A (en) * 1983-12-07 1985-03-26 Smithkline Beckman Corporation Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine
US4574129A (en) * 1984-01-31 1986-03-04 Bristol-Myers Company Topical nonsteroidal anti-inflammatory methods
US5155268A (en) * 1984-05-04 1992-10-13 The Upjohn Company Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4920116A (en) * 1985-06-28 1990-04-24 Schering A.G. N-(aminoalkyl)-substituted(N or C alkyl)-aryl-4(methylsulfonylamino)benzamides
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
GB8707120D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
US4857651A (en) * 1987-07-29 1989-08-15 American Cyanamid Company α-(2,3-Di(C1 -C4 alkoxy)ethylamino)-β-cyanostyrene and β-nitrostyrene compounds useful as intermediates in the preparation of insecticidal, acaricidal and nematicidal arylpyrroles and method for the preparation thereof
PH25458A (en) * 1987-08-24 1991-07-01 Eisai Co Ltd Piperidine derivatives, therapeutic, preventive agents
GB8909273D0 (en) * 1989-04-24 1989-06-07 Glaxo Group Ltd Chemical compounds
US5405997A (en) * 1989-07-25 1995-04-11 The Upjohn Company Antiarrhythmic methanesulfonamides
US5360822A (en) * 1990-02-07 1994-11-01 Nippon Shinyaku Co. Ltd. Sulfonanilide derivatives and medicine
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
ES2122038T3 (es) * 1992-08-26 1998-12-16 Procter & Gamble Correa para la fabricacion de papel con configuracion semicontinua y papel fabricado sobre ella.
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5874475A (en) * 1995-12-21 1999-02-23 Pharmacia & Upjohn Company Antiarrhythmic (S)-enantiomers of methanesulfonamides
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US6660772B2 (en) 2001-02-01 2003-12-09 Boehringer Ingelheim Pharma Kg Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence
DE10104369A1 (de) * 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
JP4901474B2 (ja) 2003-05-30 2012-03-21 ランバクシー ラボラトリーズ リミテッド 置換ピロール誘導体
KR20070104942A (ko) * 2005-02-21 2007-10-29 론자 아게 거울상적으로 순수한 1-치환-3-아미노알코올의 제조 방법
KR101329112B1 (ko) 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
AU2008210637B2 (en) * 2007-01-31 2012-08-16 Toray Industries, Inc. Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
JP5597992B2 (ja) * 2008-07-31 2014-10-01 東レ株式会社 ベンジルアミン誘導体又はその薬学的に許容される酸付加塩を含有する糖尿病、肥満症、脂質異常症若しくはメタボリックシンドロームの治療剤又は予防剤
EA201100654A1 (ru) 2008-10-22 2012-01-30 Акусела, Инк. Соединения для лечения офтальмологических заболеваний и расстройств
US10793519B2 (en) 2018-05-02 2020-10-06 Academic Pharmaceuticals Incorporated Ultra short acting anti-arrhythmic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH364248A (de) * 1957-12-24 1962-09-15 Geigy Ag J R Verfahren zur Herstellung neuer Aminobenzoesäure-Derivate

Also Published As

Publication number Publication date
FR3027M (fr) 1964-12-28
FR148F (xx)
SE334368B (xx) 1971-04-26
BR6346374D0 (pt) 1973-05-24
DE1493955B2 (de) 1976-11-18
DK122662B (da) 1972-03-27
FR95660E (fr) 1971-04-16
US3341584A (en) 1967-09-12
CH475962A (de) 1969-07-31
DE1493955A1 (de) 1971-08-19
FR1599658A (xx) 1970-07-20
GB993584A (xx)

Similar Documents

Publication Publication Date Title
NL139523B (nl) Werkwijze voor de bereiding van farmacologisch actieve verbindingen die de activiteit van gladde spieren beinvloeden.
NL167431C (nl) Werkwijze voor de bereiding van een histaminolytisch werkend preparaat en werkwijze voor de bereiding van een histaminolytisch werkend 4-(1-alkyl-4-piperidyli- deen)benzoŸ4,5ŸcycloheptaŸ1,2-bŸthiofeen
NL143908B (nl) Werkwijze voor de continue bereiding van isocyanaten.
NL154517B (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat werkzaam als hematicum en een werkwijze voor de bereiding van een als zodanig werkzame verbinding.
NL140266B (nl) Werkwijze voor de bereiding van polyurethanschuim.
NL144052B (nl) Werkwijze voor de bereiding van zuurstofrijke lucht.
NL141095B (nl) Werkwijze voor de allylalkylering van koolwaterstoffen.
NL145221B (nl) Werkwijze voor de bereiding van thermolabiele urethanen.
NL140529B (nl) Werkwijze voor het zuiveren van een alfa-aminobenzylpenicilline.
NL144171B (nl) Werkwijze voor het bereiden van een oxydatiekatalysator en met behulp van deze werkwijze verkregen katalysatortabletten.
FI46072C (fi) Menetelmä terapeuttisesti vaikuttavien 3-asyylioksi-3H-1,2-dihydro-1,4 -bentsodiatsepiini-2-onien valmistamiseksi.
NL140850B (nl) Werkwijze voor de bereiding van alfa-pyrrolidon.
NL148915B (nl) Werkwijze voor de bereiding van poly-epsilon-caprolactam.
NL171466C (nl) Werkwijze voor de bereiding van een gemakklijk grafiteerbaar elektrodenpek.
NL141179B (nl) Werkwijze en inrichting voor de bereiding van ureum.
NL138955B (nl) Werkwijze voor de bereiding van een lineair gesegmenteerd elastomeer.
NL148237B (nl) Werkwijze voor de bereiding van mucolytisch werkzame preparaten.
NL139454B (nl) Werkwijze voor de bereiding van verbindingen, die een anti-ontstekingswerkzaamheid bezitten, alsmede van preparaten met anti-ontstekingswerkzaamheid, die deze verbindingen als werkzame stof bevatten.
NL144279B (nl) Werkwijze voor de bereiding van 3-amino-isoxazolen.
NL146484B (nl) Werkwijze voor de bereiding van choleretisch werkzame verbindingen.
NL140882B (nl) Werkwijze voor de bereiding van polyurethanen.
NL152442B (nl) Werkwijze voor de bereiding van hartige hapjes.
NL141177B (nl) Werkwijze voor de bereiding van herbicide werkzame amidofenylcarbamaten.
NL154726B (nl) Werkwijze voor het bereiden van farmacologisch actieve verbindingen, die de activiteit van gladde spieren beinvloeden.
NL142141B (nl) Werkwijze voor de bereiding van primaire alkanolen.

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: MEAD JOHNSON

V4 Discontinued because of reaching the maximum lifetime of a patent